Sterilgarda is proud to announce its partnership as the official sponsor of the Rea Palus Race 2026, one of Italy’s most exciting OCR (Obstacle Course Racing) events, dedicated to outdoor sports enthusiasts, personal challenges, and pushing beyond one’s limits.
The 2026 circuit will take participants through some of the most stunning locations in Liguria, including Genoa, Camogli, and Portovenere, featuring courses with both natural and artificial obstacles designed for athletes, sports enthusiasts, and participants of all skill levels. It is an immersive experience that combines sport, nature, physical endurance, and team spirit in a format capable of engaging thousands of people.
The Rea Palus Race is much more than a sporting competition: it is an event that enhances the local territory, fosters connections between people, and promotes a culture of movement driven by passion, determination, and shared experiences.
This collaboration is rooted in the values that Sterilgarda and Rea Palus Race have in common. Sterilgarda has always supported initiatives that encourage a dynamic, positive, and wellness-oriented lifestyle, backing events that place energy, commitment, and participation at their core.
Through this sponsorship, Sterilgarda reaffirms its commitment to supporting sports and community-based projects that encourage social interaction, inclusion, and the active involvement of local communities. Sport is a powerful tool for creating authentic experiences and meaningful moments of connection that leave a lasting positive impact.
Throughout the various stages of the Rea Palus Race 2026, professional athletes, teams, and amateur participants will challenge themselves on highly engaging courses featuring coastal landscapes, trails, mud, and technical obstacles, creating an intense and rewarding experience.
Sterilgarda will be part of this adventure, sharing the energy and excitement of every stage while supporting an event that brings together sport, local communities, and people in one extraordinary experience.